RETRACTED ARTICLE: Breast cancer prognosis and immunological characteristics are predicted using the m6A/m5C/m1A/m7G-related long noncoding RNA signature
Authors:
- 4 April 2023
- journal article
- retracted article
- Published by Springer Nature in Functional & Integrative Genomics
- Vol. 23 (2) , 1-14
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Tumor Microenvironment, Metabolism, and ImmunotherapyNew England Journal of Medicine, 2020
- Tumor mutation burden, immune checkpoint crosstalk and radiosensitivity in single-cell RNA sequencing data of breast cancerRadiotherapy and Oncology, 2020
- TIGIT as an emerging immune checkpointClinical and Experimental Immunology, 2019
- Epidemiology of Breast Cancer in Women2019
- CXCR4 antagonism in combination with IDO1 inhibition weakens immune suppression and inhibits tumor growth in mouse breast cancer bone metastasesOncoTargets and Therapy, 2019
- The role of m6A RNA methylation in cancerBiomedicine & Pharmacotherapy, 2019
- Long noncoding RNAs as regulators of cancer immunityMolecular Oncology, 2018
- Long Noncoding RNA and Cancer: A New ParadigmCancer Research, 2017
- siRNA-Mediated suppression of collagen type iv alpha 2 (COL4A2) mRNA inhibits triple-negative breast cancer cell proliferation and migrationOncotarget, 2016
- ConsensusClusterPlus: a class discovery tool with confidence assessments and item trackingBioinformatics, 2010